v3.25.1
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Class A Common Stock
Class B Common Stock
Common Stock
Class A Common Stock
Common Stock
Class B Common Stock
Additional Paid-In Capital
Accumulated Deficit
Balance at beginning of the period (in shares) at Dec. 31, 2023       181,221,794 26,426,937    
Balance at beginning of the period at Dec. 31, 2023 $ 220,053     $ 18 $ 3 $ 949,670 $ (729,638)
Increase (Decrease) in Stockholders' Equity              
Net loss (21,761)           (21,761)
Common stock issued upon vesting of restricted stock units (in shares)       2,992,583      
Stock-based compensation expense 5,712         5,712  
Balance at end of the period (in shares) at Mar. 31, 2024       184,214,377 26,426,937    
Balance at end of the period at Mar. 31, 2024 204,004     $ 18 $ 3 955,382 (751,399)
Balance at beginning of the period (in shares) at Dec. 31, 2024   188,626,154 26,426,937 188,626,154 26,426,937    
Balance at beginning of the period at Dec. 31, 2024 168,832     $ 19 $ 3 970,940 (802,130)
Increase (Decrease) in Stockholders' Equity              
Net loss (13,967)           (13,967)
Net proceeds from share offering (in shares)       27,600,000      
Net proceeds from share offering $ 81,109     $ 3   81,106  
Common stock issued upon exercise of stock options (in shares) 79,827     79,827      
Common stock issued upon exercise of stock options $ 133         133  
Common stock issued upon vesting of restricted stock units (in shares)       4,512,667      
Common stock issued upon vesting of restricted stock units, net (2,775)         (2,775)  
Stock-based compensation expense 6,364         6,364  
Balance at end of the period (in shares) at Mar. 31, 2025   220,818,648 26,426,937 220,818,648 26,426,937    
Balance at end of the period at Mar. 31, 2025 $ 239,696     $ 22 $ 3 $ 1,055,768 $ (816,097)